BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 47882)

  • 1. Early and enhanced antioxin responses elicited with complexes of tetanus toxoid and specific mouse and human antibodies.
    Stoner RD; Terres G; Hess MW
    J Infect Dis; 1975 Mar; 131(3):230-8. PubMed ID: 47882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active-passive immunization of human subjects against tetanus using homologous gamma globulin.
    Matveev KI; Skurkovich SV; Bychenko BD; Kasparova EM; Konstantinova ND; Minaeva HL
    J Hyg Epidemiol Microbiol Immunol; 1974; 18(2):246-51. PubMed ID: 4137523
    [No Abstract]   [Full Text] [Related]  

  • 3. The differences in immunizing capacity between various tetanus toxoids in active-passive immunization with human antitoxin.
    Cohen H; Peetoom F; van Ramshorst JD
    Prog Immunobiol Stand; 1970; 4():527-32. PubMed ID: 5482197
    [No Abstract]   [Full Text] [Related]  

  • 4. Active immunization against tetanus in man. III. Antibody response to vaccine injections in the presence of therapeutic doses of human tetanus immune globulin. a record of five cases.
    Ullberg-Olsson K
    Eur Surg Res; 1975; 7(6):305-14. PubMed ID: 1183456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization against neonatal tetanus in New Guinea.
    Hardegree MC; Barile MF; Pittman M; Schofield FD; Maclennan R; Kelly A
    Bull World Health Organ; 1970; 43(3):439-51. PubMed ID: 5312998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral immunization against tetanus, using liposome-entrapped tetanus toxoid].
    Hiraga C; Ishii F; Ichikawa Y
    Kansenshogaku Zasshi; 1989 Dec; 63(12):1308-12. PubMed ID: 2621384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active-passive tetanus immunization. Choice of toxoid, dose of tetanus immune globulin and timing of injections.
    Levine L; McComb JA; Dwyer RC; Latham WC
    N Engl J Med; 1966 Jan; 274(4):186-90. PubMed ID: 4159253
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphoid cell dependence of eosinophil response to antigen. VI. The effect of selective removal of T or B lymphocytes on the capacity of primed spleen cells to adoptively transferred immunity to tetanus toxoid.
    Ponzio NM; Speirs RS
    Immunology; 1975 Feb; 28(2):243-51. PubMed ID: 1079015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germinal center kinetics in lymph nodes of primed mice stimulated with complexed as opposed to free antigen.
    Buerki H; Kraft R; Hess MW; Laissue J; Cottier H; Stoner RD
    Immunol Lett; 1989 Dec; 23(2):87-94. PubMed ID: 2632373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined active-passive immunization against tetanus in man.
    Mahoney LJ; Aprile MA; Moloney PJ
    Can Med Assoc J; 1967 May; 96(21):1401-4. PubMed ID: 6026992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfer rate of transplacental immunity to tetanus from non-immunized and immunized mothers.
    Sangpetchsong V; Vichaikummart S; Vichitnant A; Podhipak A
    Southeast Asian J Trop Med Public Health; 1984 Sep; 15(3):275-80. PubMed ID: 6523168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active immunization against tetanus in man. II. Combined active and passive prophylaxis with human tetanus immune globulin.
    Ullberg Olsson K; Eriksson E; Lundström R; Wiholm S
    Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(3):191-201. PubMed ID: 134538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental investigations on oral immunization with tetanus-toxoid (author's transl)].
    Baljer G; Starflinger H; Sorg KH; Sailer J; Mayr A
    Zentralbl Bakteriol Orig A; 1975 Aug; 232(4):488-98. PubMed ID: 1199521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates of cellular and antibody incorporation of 3H-histidine in mice during secondary responses to tetanus toxoid.
    Stucki M; Hess MW; Cottier H; Hankes LV; Stoner RD
    J Reticuloendothel Soc; 1974 Jun; 15(6):453-65. PubMed ID: 4854033
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on adjuvants for human prophylactics. II. Influence of the route of injection on the activity of adjuvants to tetanus toxoid in guinea pigs.
    Yamamoto A; Murata R
    Jpn J Med Sci Biol; 1978; 31(5-6):393-406. PubMed ID: 156804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The early primary immune response to absorbed tetanus toxoid in man: A study of the influence of antigen concentration, carrier concentration, and sequence of dosage on the rate, extent, and persistence of the immune response to one and to two doses of toxoid.
    Maclennan R; Levine L; Newell KW; Edsall G
    Bull World Health Organ; 1973; 49(6):615-26. PubMed ID: 4548388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunity in guinea pigs following administration of tetanus toxin, antitoxin and anatoxin].
    Tuczapska B
    Pol Tyg Lek; 1972 Dec; 27(51):2023-5. PubMed ID: 4653716
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current status of preventive measures in tetanus].
    Eckmann L
    Langenbecks Arch Chir; 1969; 325():937-40. PubMed ID: 4190266
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of 1,500 units and 5,000 units of tetanus antitoxin in simultaneous active and passive immunization against tetanus.
    Vakil BJ; Tulpule TH; Rao SS; Borker MB
    Indian J Med Res; 1968 Aug; 56(8):1188-201. PubMed ID: 5711600
    [No Abstract]   [Full Text] [Related]  

  • 20. Tetanus antitoxin production and gamma globulin levels in patients with cirrhosis of the liver.
    Bjorneboe M; Jensen KB; Scheibel I; Thomsen AC; Bentzon MW
    Acta Med Scand; 1970 Dec; 188(6):541-6. PubMed ID: 4099773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.